Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 1/2014

01-09-2014 | Case Report

Diffuse Large B Cell Lymphoma in Wiskott-Aldrich Syndrome: A Case Report and Review of Literature

Authors: Jayastu Senapati, Anup J. Devasia, Sachin David, Marie Therese Manipadam, Sheila Nair, Giridhara R. Jayandharan, Biju George

Published in: Indian Journal of Hematology and Blood Transfusion | Special Issue 1/2014

Login to get access

Abstract

Wiskott-Aldrich syndrome (WAS) is an X linked rare primary immunodeficiency syndrome with an increased propensity for infection, autoimmunity and malignancy. Here we report a male child, who was diagnosed with WAS at 1 year of age following evaluation for symptomatic thrombocytopenia and eczematous skin lesions. He presented later with lymphadenopathy, which was consistent with diffuse large B cell lymphoma on histopathology. He received 6 cycles of R-CHOP chemotherapy for the same and is presently in remission after 6 months. We review the major publications of lymphoma in WAS and discuss the pathological findings, treatment and prognosis of lymphoma in WAS.
Literature
1.
2.
go back to reference Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA (1994) A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr 125(6, Part 1):876–885PubMedCrossRef Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA (1994) A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr 125(6, Part 1):876–885PubMedCrossRef
3.
go back to reference Bosticardo M, Marangoni F, Aiuti A, Villa A, Grazia Roncarolo M (2009) Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome. Blood 113(25):6288–6295PubMedCrossRef Bosticardo M, Marangoni F, Aiuti A, Villa A, Grazia Roncarolo M (2009) Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome. Blood 113(25):6288–6295PubMedCrossRef
4.
go back to reference Cotelingam JD, Witebsky FG, Hsu SM, Blaese RM, Jaffe ES (1985) Malignant lymphoma in patients with the Wiskott-Aldrich syndrome. Cancer Invest 3(6):515–522PubMedCrossRef Cotelingam JD, Witebsky FG, Hsu SM, Blaese RM, Jaffe ES (1985) Malignant lymphoma in patients with the Wiskott-Aldrich syndrome. Cancer Invest 3(6):515–522PubMedCrossRef
5.
go back to reference Kwan SP, Hagemann TL, Radtke BE, Blaese RM, Rosen FS (1995) Identification of mutations in the Wiskott-Aldrich syndrome gene and characterization of a polymorphic dinucleotide repeat at DXS6940, adjacent to the disease gene. Proc Natl Acad Sci 92(10):4706–4710PubMedCrossRefPubMedCentral Kwan SP, Hagemann TL, Radtke BE, Blaese RM, Rosen FS (1995) Identification of mutations in the Wiskott-Aldrich syndrome gene and characterization of a polymorphic dinucleotide repeat at DXS6940, adjacent to the disease gene. Proc Natl Acad Sci 92(10):4706–4710PubMedCrossRefPubMedCentral
6.
go back to reference Jayandharan G, Viswabandya A, Baidya S, Nair SC, Shaji RV, George B et al (2005) Six novel mutations including triple heterozygosity for Phe31Ser, 514delT and 516T→ G factor X gene mutations are responsible for congenital factor X deficiency in patients of Nepali and Indian origin. J Thromb Haemost 3(7):1482–1487PubMedCrossRef Jayandharan G, Viswabandya A, Baidya S, Nair SC, Shaji RV, George B et al (2005) Six novel mutations including triple heterozygosity for Phe31Ser, 514delT and 516T→ G factor X gene mutations are responsible for congenital factor X deficiency in patients of Nepali and Indian origin. J Thromb Haemost 3(7):1482–1487PubMedCrossRef
7.
go back to reference Remold-O’Donnell E, Rosen FS, Kenney DM (1996) Defects in Wiskott-Aldrich syndrome blood cells. Blood 87(7):2621–2631PubMed Remold-O’Donnell E, Rosen FS, Kenney DM (1996) Defects in Wiskott-Aldrich syndrome blood cells. Blood 87(7):2621–2631PubMed
9.
go back to reference Derry JMJ, Ochs HD, Francke U (1994) Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 78(4):635–644PubMedCrossRef Derry JMJ, Ochs HD, Francke U (1994) Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 78(4):635–644PubMedCrossRef
10.
go back to reference Villa A, Notarangelo L, Macchi P, Mantuano E, Cavagni G, Brugnoni D et al (1995) X–linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene. Nat Genet 9(4):414–417PubMedCrossRef Villa A, Notarangelo L, Macchi P, Mantuano E, Cavagni G, Brugnoni D et al (1995) X–linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene. Nat Genet 9(4):414–417PubMedCrossRef
11.
go back to reference Devriendt K, Kim AS, Mathijs G, Frints SG, Schwartz M, Van den Oord JJ et al (2001) Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet 27(3):313–317PubMedCrossRef Devriendt K, Kim AS, Mathijs G, Frints SG, Schwartz M, Van den Oord JJ et al (2001) Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet 27(3):313–317PubMedCrossRef
12.
13.
go back to reference Ten Bensel RW, Stadlan EM, Krivit W (1966) The development of malignancy in the course of the Aldrich syndrome. J Pediatr 68(5):761–767PubMedCrossRef Ten Bensel RW, Stadlan EM, Krivit W (1966) The development of malignancy in the course of the Aldrich syndrome. J Pediatr 68(5):761–767PubMedCrossRef
14.
go back to reference Frizzera G, Rosai J, Dehner LP, Spector BD, Kersey JH (1980) Lymphoreticular disorders in primary immunodeficiencies: new findings based on an up-to-date histologic classification of 35 cases. Cancer 46(4):692–699PubMedCrossRef Frizzera G, Rosai J, Dehner LP, Spector BD, Kersey JH (1980) Lymphoreticular disorders in primary immunodeficiencies: new findings based on an up-to-date histologic classification of 35 cases. Cancer 46(4):692–699PubMedCrossRef
15.
go back to reference Yoshida K, Minegishi Y, Okawa H, Yata J, Tokoi S, Kitagawa T et al (1997) Epstein-Barr virus-associated malignant lymphoma with macroamylasemia and monoclonal gammopathy in a patient with Wiskott-Aldrich syndrome. Pediatr Hematol Oncol 14(1):85–89PubMedCrossRef Yoshida K, Minegishi Y, Okawa H, Yata J, Tokoi S, Kitagawa T et al (1997) Epstein-Barr virus-associated malignant lymphoma with macroamylasemia and monoclonal gammopathy in a patient with Wiskott-Aldrich syndrome. Pediatr Hematol Oncol 14(1):85–89PubMedCrossRef
17.
go back to reference Kroft S, Finn W, Singleton T, Ross C, Sheldon S, Schnitzer B (1998) Follicular large cell lymphoma with immunoblastic features in a child with Wiskott-Aldrich syndrome: an unusual immunodeficiency-related neoplasm not associated with Epstein-Barr virus. Am J Clin Pathol 110(1):95–99PubMed Kroft S, Finn W, Singleton T, Ross C, Sheldon S, Schnitzer B (1998) Follicular large cell lymphoma with immunoblastic features in a child with Wiskott-Aldrich syndrome: an unusual immunodeficiency-related neoplasm not associated with Epstein-Barr virus. Am J Clin Pathol 110(1):95–99PubMed
18.
go back to reference Faraci RP, Hoffstrand HJ, Witebsky FG, Blaese R, Beazley RM (1975) Malignant lymphoma of the jejunum in a patient with Wiskott-Aldrich syndrome: surgical treatment. Arch Surg 110(2):218–220PubMedCrossRef Faraci RP, Hoffstrand HJ, Witebsky FG, Blaese R, Beazley RM (1975) Malignant lymphoma of the jejunum in a patient with Wiskott-Aldrich syndrome: surgical treatment. Arch Surg 110(2):218–220PubMedCrossRef
19.
go back to reference Du S, Scuderi R, Malicki DM, Willert J, Bastian J, Weidner N (2010) Hodgkin’s and non-Hodgkin’s lymphomas occurring in two brothers with Wiskott-Aldrich syndrome and review of the literature. Pediatr Dev Pathol 14(1):64–70PubMedCrossRef Du S, Scuderi R, Malicki DM, Willert J, Bastian J, Weidner N (2010) Hodgkin’s and non-Hodgkin’s lymphomas occurring in two brothers with Wiskott-Aldrich syndrome and review of the literature. Pediatr Dev Pathol 14(1):64–70PubMedCrossRef
20.
go back to reference Coccia P, Mastrangelo S, Ruggiero A, Scalzone M, Rosolen A, Maurizi P et al (2012) Treatment of pharyngeal non-Hodgkin lymphoma in a patient with Wiskott-Aldrich syndrome. Pediatr Blood Cancer 59(2):318–319PubMedCrossRef Coccia P, Mastrangelo S, Ruggiero A, Scalzone M, Rosolen A, Maurizi P et al (2012) Treatment of pharyngeal non-Hodgkin lymphoma in a patient with Wiskott-Aldrich syndrome. Pediatr Blood Cancer 59(2):318–319PubMedCrossRef
21.
go back to reference Gilson D, Taylor R (1999) Long-term survival following non-Hodgkin’s lymphoma arising in Wiskott-Aldrich syndrome. Clin Oncol 11(4):283–285CrossRef Gilson D, Taylor R (1999) Long-term survival following non-Hodgkin’s lymphoma arising in Wiskott-Aldrich syndrome. Clin Oncol 11(4):283–285CrossRef
22.
go back to reference Tavil B, Erdem AY, Azik F, Isik P, Metin A, Emir S et al (2013) Successful allogeneic hemopoietic stem cell transplantation in a case of Wiskott-Aldrich syndrome and non-Hodgkin lymphoma. Pediatr Transplant 17(6):E146–E148PubMedCrossRef Tavil B, Erdem AY, Azik F, Isik P, Metin A, Emir S et al (2013) Successful allogeneic hemopoietic stem cell transplantation in a case of Wiskott-Aldrich syndrome and non-Hodgkin lymphoma. Pediatr Transplant 17(6):E146–E148PubMedCrossRef
23.
go back to reference Perry GS III, Spector BD, Schuman LM, Mandel JS, Anderson VE, McHugh RB et al (1980) The Wiskott-Aldrich syndrome in the United States and Canada (1892–1979). J Pediatr 97(1):72–78PubMedCrossRef Perry GS III, Spector BD, Schuman LM, Mandel JS, Anderson VE, McHugh RB et al (1980) The Wiskott-Aldrich syndrome in the United States and Canada (1892–1979). J Pediatr 97(1):72–78PubMedCrossRef
24.
go back to reference Palenzuela G, Bernard F, Gardiner Q, Mondain M (2003) Malignant B cell non-Hodgkin’s lymphoma of the larynx in children with Wiskott-Aldrich syndrome. Int J Pediatr Otorhinolaryngol 67(9):989–993PubMedCrossRef Palenzuela G, Bernard F, Gardiner Q, Mondain M (2003) Malignant B cell non-Hodgkin’s lymphoma of the larynx in children with Wiskott-Aldrich syndrome. Int J Pediatr Otorhinolaryngol 67(9):989–993PubMedCrossRef
25.
go back to reference Nakanishi M, Kikuta H, Tomizawa K, Kojima K, Ishizaka A, Okano M et al (1993) Distinct clonotypic Epstein-Barr virus-induced fatal lymphoproliferative disorder in a patient with Wiskott-Aldrich syndrome. Cancer 72(4):1376–1381PubMedCrossRef Nakanishi M, Kikuta H, Tomizawa K, Kojima K, Ishizaka A, Okano M et al (1993) Distinct clonotypic Epstein-Barr virus-induced fatal lymphoproliferative disorder in a patient with Wiskott-Aldrich syndrome. Cancer 72(4):1376–1381PubMedCrossRef
26.
go back to reference Kawakami K, Yamaguchi M, Watanabe Y, Murata T (2002) Development of Diffuse Large Cell Lymphoma from Follicular Lymphoma with Multiple Immunoglobulin Heavy Chain Gene Rearrangement Occurring in a Patient with Wiskott-Aldrich Syndrome. Int J Hematol 76(2):196–198PubMedCrossRef Kawakami K, Yamaguchi M, Watanabe Y, Murata T (2002) Development of Diffuse Large Cell Lymphoma from Follicular Lymphoma with Multiple Immunoglobulin Heavy Chain Gene Rearrangement Occurring in a Patient with Wiskott-Aldrich Syndrome. Int J Hematol 76(2):196–198PubMedCrossRef
27.
go back to reference Periman P, Callihan TR, Lessin L, King GW, Blaese M (1980) Hodgkin’s disease occurring in a patient with the Wiskott-Aldrich syndrome. Cancer 45(2):372–376PubMedCrossRef Periman P, Callihan TR, Lessin L, King GW, Blaese M (1980) Hodgkin’s disease occurring in a patient with the Wiskott-Aldrich syndrome. Cancer 45(2):372–376PubMedCrossRef
28.
go back to reference Sebire NJ, Haselden S, Malone M, Davies EG, Ramsay AD (2003) Isolated EBV lymphoproliferative disease in a child with Wiskott-Aldrich syndrome manifesting as cutaneous lymphomatoid granulomatosis and responsive to anti-CD20 immunotherapy. J Clin Pathol 56(7):555–557PubMedCrossRefPubMedCentral Sebire NJ, Haselden S, Malone M, Davies EG, Ramsay AD (2003) Isolated EBV lymphoproliferative disease in a child with Wiskott-Aldrich syndrome manifesting as cutaneous lymphomatoid granulomatosis and responsive to anti-CD20 immunotherapy. J Clin Pathol 56(7):555–557PubMedCrossRefPubMedCentral
Metadata
Title
Diffuse Large B Cell Lymphoma in Wiskott-Aldrich Syndrome: A Case Report and Review of Literature
Authors
Jayastu Senapati
Anup J. Devasia
Sachin David
Marie Therese Manipadam
Sheila Nair
Giridhara R. Jayandharan
Biju George
Publication date
01-09-2014
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue Special Issue 1/2014
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-014-0377-1

Other articles of this Special Issue 1/2014

Indian Journal of Hematology and Blood Transfusion 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine